Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of shareholdings in Euroclear plc

24 Oct 2017 17:37

RNS Number : 5129U
Royal Bank of Scotland Group PLC
24 October 2017
 

Royal Bank of Scotland Group PLC

24 October 2017

 

Disposal of shareholdings in Euroclear plc

 

The Royal Bank of Scotland Group plc ("RBS") announces that its subsidiaries have today entered into an agreement to dispose of RBS' entire shareholdings in Euroclear plc to IntercontinentalExchange Holdings.

 

The transaction, which was also completed today, involved the sale of 148,349 ordinary shares in Euroclear plc for a total cash consideration of €275 million (approximately £245 million at current exchange rates)*. KPMG Corporate Finance acted as financial advisers to RBS and Simmons & Simmons acted as legal advisers to RBS on this transaction.

 

The sale proceeds will be used for general corporate purposes. The transaction is part of the continued reduction of assets in RBS and is in line with the bank's plan to strengthen its capital position.The carrying value of the shareholding in Euroclear plc as at 30 June 2017 was approximately £88 million, which represents RWA equivalent of around £220 million. The transaction is expected to generate a gain of approximately £175 million after associated costs, reserves recycling and before tax, which will be recognised as a gain on strategic disposal in Q4 2017.

 

For further information, please contact:

RBS Investor RelationsMatt WaymarkHead of Investor RelationsTel: +44 (0) 20 7672 1758

 * Under the terms of the sale agreement, additional consideration may become payable in certain circumstances if the purchaser either resells Euroclear plc shares acquired pursuant to this transaction or acquires further shares in Euroclear plc, in each case at or above certain agreed pricing thresholds within a specified period following completion.

FORWARD LOOKING STATEMENTS

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including (but not limited to) those with respect to RBS and its subsidiaries' regulatory capital position, financial position, risk-weighted assets, profitability and financial performance and the implementation of RBS's transformation programme under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements containing words such as "intends", "believes", "expects", "anticipates", "targets", "plans", "will" and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and ability to achieve current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed in, or implied by, the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's 2016 Annual Report and Accounts (ARA) and its interim results for the six-months ended 30 June 2017 and materials filed with, or furnished to, the United States Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this announcement speak only as of the date they are made or revised and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

Legal Entity Identifier: 2138005O9XJIJN4JPN90, RR3QWICWWIPCS8A4S074

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISMIBFTMBTTBFR
Date   Source Headline
9th Apr 20146:15 pmRNSDAS - Revised State Aid Terms
8th Apr 20144:20 pmRNSBlock Listing Return
8th Apr 20144:06 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSDirectorate Change
2nd Apr 201412:55 pmRNSHolding(s) in Company
31st Mar 20145:29 pmRNSTotal Voting Rights
28th Mar 20149:39 amRNSRBSG SEC Registered Senior Notes Transaction
26th Mar 20146:19 pmRNSStabilisation Notice
25th Mar 20148:46 amRNSMorgan Stanley European Financials Conference
24th Mar 20143:53 pmRNSPublication of Final Terms
19th Mar 20141:49 pmRNSPublication of Prospectus
10th Mar 20145:51 pmRNSPublication of Prospectus
10th Mar 20144:51 pmRNSDirector/PDMR Shareholding
7th Mar 20146:24 pmRNSPublication of Registration Document
7th Mar 20141:10 pmRNSDirectorate Change
7th Mar 20141:00 pmRNSDirector/PDMR Shareholding
7th Mar 20141:00 pmRNSInvestor Meeting
28th Feb 20145:26 pmRNSTotal Voting Rights
28th Feb 20143:30 pmRNSDirector/PDMR Shareholding
28th Feb 201412:30 pmRNSAdditional Listing
27th Feb 20147:03 amRNSCompletion of Sale of Remaining Interest in DLG
27th Feb 20147:01 amRNSDirectorate Change
27th Feb 20147:01 amRNSFinal Results - Part 6 of 6
27th Feb 20147:01 amRNSFinal Results - Part 5 of 6
27th Feb 20147:01 amRNSFinal Results - Part 4 of 6
27th Feb 20147:01 amRNSFinal Results - Part 3 of 6
27th Feb 20147:01 amRNSFinal Results - Part 2 of 6
27th Feb 20147:00 amRNSFinal Results - Part 1 of 6
26th Feb 20144:57 pmRNSIntention to Sell Remaining Interest in DLG
21st Feb 20144:14 pmRNSDividend Declaration
19th Feb 20149:00 amRNSRBS Structured Retail IP&ED Business
10th Feb 201410:35 amRNSDirector/PDMR Shareholding
3rd Feb 20145:19 pmRNSCorrection: Total Voting Rights
31st Jan 20144:24 pmRNSHolding(s) in Company
31st Jan 20143:24 pmRNSTotal Voting Rights
27th Jan 20144:06 pmRNSTrading Update
16th Jan 20145:00 pmRNSHolding(s) in Company
15th Jan 201412:47 pmRNSRBS AND RBS NV ANNOUNCE CASH TENDER OFFER RESULTS
9th Jan 20141:30 pmRNSNotification of Major Interest in Shares
8th Jan 20149:13 amRNSDirector/PDMR Shareholding
7th Jan 20142:04 pmRNSSale of selected Chicago-area operations
31st Dec 201312:36 pmRNSTotal Voting Rights
31st Dec 201312:30 pmRNSDirector/PDMR Shareholding
19th Dec 20134:59 pmRNSPublication of Prospectus
17th Dec 201310:54 amRNSRBSG announces $2 billion T2 Notes transaction
16th Dec 20136:24 pmRNSEU-wide EBA Transparency Exercise
16th Dec 20135:07 pmRNSRBS cancels contingent capital facility with HMT
11th Dec 20136:13 pmRNSRBS Reaches Settlement Regarding OFAC Compliance
11th Dec 20137:00 amRNSRBS confirms Nathan Bostock to resign
9th Dec 20136:20 pmRNSALLOTMENT AND ISSUE OF NEW ORDINARY SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.